vs
Definitive Healthcare Corp.（DH）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Definitive Healthcare Corp.的1.1倍（$69.8M vs $61.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -15.1%，领先399.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -1.5%）
该企业是一家美国公司，主打非处方医疗健康产品与家居清洁产品的营销和分销。公司于1996年由美德泰产品公司、威望品牌国际与斯皮克Span公司合并成立，总部设在纽约塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DH vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.5M
营收增速更快
RIGL
高出22.4%
-1.2%
净利率更高
RIGL
高出399.2%
-15.1%
两年增速更快
RIGL
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.5M | $69.8M |
| 净利润 | $-9.3M | $268.1M |
| 毛利率 | 76.2% | 91.5% |
| 营业利润率 | -43.3% | 33.2% |
| 净利率 | -15.1% | 384.0% |
| 营收同比 | -1.2% | 21.2% |
| 净利润同比 | 84.2% | 1769.2% |
| 每股收益（稀释后） | $-0.14 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHRIGL
| Q4 25 | $61.5M | $69.8M | ||
| Q3 25 | $60.0M | $69.5M | ||
| Q2 25 | $60.8M | $101.7M | ||
| Q1 25 | $59.2M | $53.3M | ||
| Q4 24 | $62.3M | $57.6M | ||
| Q3 24 | $62.7M | $55.3M | ||
| Q2 24 | $63.7M | $36.8M | ||
| Q1 24 | $63.5M | $29.5M |
净利润DHRIGL
| Q4 25 | $-9.3M | $268.1M | ||
| Q3 25 | $-14.8M | $27.9M | ||
| Q2 25 | $-7.6M | $59.6M | ||
| Q1 25 | $-107.2M | $11.4M | ||
| Q4 24 | $-59.1M | $14.3M | ||
| Q3 24 | $-130.9M | $12.4M | ||
| Q2 24 | $-213.6M | $-1.0M | ||
| Q1 24 | $-9.5M | $-8.2M |
毛利率DHRIGL
| Q4 25 | 76.2% | 91.5% | ||
| Q3 25 | 76.6% | 93.2% | ||
| Q2 25 | 76.7% | 95.6% | ||
| Q1 25 | 73.9% | 91.7% | ||
| Q4 24 | 76.4% | 89.9% | ||
| Q3 24 | 78.2% | 85.5% | ||
| Q2 24 | 79.2% | 92.4% | ||
| Q1 24 | 79.4% | 93.1% |
营业利润率DHRIGL
| Q4 25 | -43.3% | 33.2% | ||
| Q3 25 | -14.5% | 40.9% | ||
| Q2 25 | -6.9% | 60.1% | ||
| Q1 25 | -312.2% | 23.9% | ||
| Q4 24 | -159.8% | 28.9% | ||
| Q3 24 | -359.5% | 25.4% | ||
| Q2 24 | -579.9% | 1.2% | ||
| Q1 24 | -25.6% | -23.6% |
净利率DHRIGL
| Q4 25 | -15.1% | 384.0% | ||
| Q3 25 | -24.7% | 40.2% | ||
| Q2 25 | -12.4% | 58.6% | ||
| Q1 25 | -181.2% | 21.5% | ||
| Q4 24 | -94.8% | 24.9% | ||
| Q3 24 | -208.8% | 22.5% | ||
| Q2 24 | -335.2% | -2.8% | ||
| Q1 24 | -15.0% | -27.9% |
每股收益（稀释后）DHRIGL
| Q4 25 | $-0.14 | $14.11 | ||
| Q3 25 | $-0.14 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.95 | $0.63 | ||
| Q4 24 | $-0.53 | $0.82 | ||
| Q3 24 | $-1.12 | $0.70 | ||
| Q2 24 | $-1.81 | $-0.06 | ||
| Q1 24 | $-0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.9M | $155.0M |
| 总债务越低越好 | $156.1M | $52.5M |
| 股东权益账面价值 | $379.0M | $391.5M |
| 总资产 | $735.5M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.41× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DHRIGL
| Q4 25 | $180.9M | $155.0M | ||
| Q3 25 | $185.9M | $137.1M | ||
| Q2 25 | $184.2M | $108.4M | ||
| Q1 25 | $200.7M | $77.1M | ||
| Q4 24 | $290.2M | $77.3M | ||
| Q3 24 | $305.4M | $61.1M | ||
| Q2 24 | $296.5M | $49.1M | ||
| Q1 24 | $295.2M | $49.5M |
总债务DHRIGL
| Q4 25 | $156.1M | $52.5M | ||
| Q3 25 | $158.2M | $60.0M | ||
| Q2 25 | $160.3M | $60.0M | ||
| Q1 25 | $162.4M | $60.0M | ||
| Q4 24 | $229.4M | $60.0M | ||
| Q3 24 | $232.7M | $60.0M | ||
| Q2 24 | $236.0M | $60.0M | ||
| Q1 24 | $239.3M | $60.0M |
股东权益DHRIGL
| Q4 25 | $379.0M | $391.5M | ||
| Q3 25 | $389.7M | $117.6M | ||
| Q2 25 | $411.2M | $81.9M | ||
| Q1 25 | $435.9M | $18.6M | ||
| Q4 24 | $607.2M | $3.3M | ||
| Q3 24 | $695.6M | $-14.6M | ||
| Q2 24 | $886.3M | $-29.9M | ||
| Q1 24 | $1.2B | $-31.7M |
总资产DHRIGL
| Q4 25 | $735.5M | $513.6M | ||
| Q3 25 | $755.5M | $242.5M | ||
| Q2 25 | $770.1M | $206.7M | ||
| Q1 25 | $808.7M | $176.0M | ||
| Q4 24 | $1.1B | $164.0M | ||
| Q3 24 | $1.2B | $139.4M | ||
| Q2 24 | $1.4B | $128.4M | ||
| Q1 24 | $1.8B | $126.5M |
负债/权益比DHRIGL
| Q4 25 | 0.41× | 0.13× | ||
| Q3 25 | 0.41× | 0.51× | ||
| Q2 25 | 0.39× | 0.73× | ||
| Q1 25 | 0.37× | 3.23× | ||
| Q4 24 | 0.38× | 18.25× | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.7M | — |
| 自由现金流率自由现金流/营收 | -2.8% | — |
| 资本支出强度资本支出/营收 | 7.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $37.1M | — |
8季度趋势，按日历期对齐
经营现金流DHRIGL
| Q4 25 | $2.7M | $22.0M | ||
| Q3 25 | $15.7M | $24.0M | ||
| Q2 25 | $9.3M | $30.5M | ||
| Q1 25 | $26.1M | $-893.0K | ||
| Q4 24 | $8.1M | $14.5M | ||
| Q3 24 | $19.4M | $21.7M | ||
| Q2 24 | $14.0M | $302.0K | ||
| Q1 24 | $16.6M | $-5.0M |
自由现金流DHRIGL
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $13.4M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $18.4M | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $18.7M | — | ||
| Q2 24 | $13.6M | — | ||
| Q1 24 | $16.3M | — |
自由现金流率DHRIGL
| Q4 25 | -2.8% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 31.0% | — | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | 29.8% | — | ||
| Q2 24 | 21.4% | — | ||
| Q1 24 | 25.7% | — |
资本支出强度DHRIGL
| Q4 25 | 7.2% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.4% | — |
现金转化率DHRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DH
| Subscription Services | $58.5M | 95% |
| Professional Services | $3.0M | 5% |
RIGL
暂无分部数据
